• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

免疫功能低下患者中与霉菌相关疾病的风险评估和预后因素。

Risk assessment and prognostic factors for mould-related diseases in immunocompromised patients.

机构信息

Department of Hematology, Università Cattolica del Sacro Cuore, Largo Francesco Vito 1, I-00168 Rome, Italy.

出版信息

J Antimicrob Chemother. 2011 Jan;66 Suppl 1:i5-14. doi: 10.1093/jac/dkq437.

DOI:10.1093/jac/dkq437
PMID:21177404
Abstract

Invasive fungal diseases are important causes of morbidity and mortality in immunocompromised patients. Patients with haematological malignancies and solid cancers, as well as those with allogeneic haematopoietic stem cell and solid organ transplants, are at high risk of developing such an infection. Many fungi can cause invasive disease, with Aspergillus spp. and Candida spp. being the prevalent fungal pathogens infecting susceptible patients. During the past few years, rare moulds (for example Zygomycetes and Fusarium spp.) have come into focus as the cause of devastating clinical disease. This review aims to analyse environmental factors and parameters related to impairment of the immune system that are thought to favour the onset of invasive mould infections. Some moulds are quite common among all categories of patients, while others appear to be limited to a given subset of patients, such as allogeneic haematopoietic stem cell or solid organ transplant recipients. In addition to an exploration of factors that predispose patients to the acquisition of an invasive mould infection, prognostic factors that help to predict the eventual outcome of these infections are identified.

摘要

侵袭性真菌感染是免疫功能低下患者发病和死亡的重要原因。血液系统恶性肿瘤和实体瘤患者,以及异基因造血干细胞和实体器官移植患者,均有发生此类感染的高风险。许多真菌均可导致侵袭性疾病,曲霉菌属和假丝酵母菌属是侵袭性感染的主要真菌病原体。在过去几年中,罕见的霉菌(例如接合菌和镰刀菌属)已成为引起破坏性临床疾病的关注焦点。本综述旨在分析环境因素和与免疫系统受损相关的参数,这些因素被认为有利于侵袭性霉菌感染的发生。一些霉菌在所有类型的患者中都很常见,而另一些霉菌似乎仅局限于特定的患者亚群,如异基因造血干细胞或实体器官移植受者。除了探讨使患者易患侵袭性霉菌感染的因素外,还确定了有助于预测这些感染最终结果的预后因素。

相似文献

1
Risk assessment and prognostic factors for mould-related diseases in immunocompromised patients.免疫功能低下患者中与霉菌相关疾病的风险评估和预后因素。
J Antimicrob Chemother. 2011 Jan;66 Suppl 1:i5-14. doi: 10.1093/jac/dkq437.
2
Risk factors for invasive fungal infections in haematopoietic stem cell transplantation.造血干细胞移植中侵袭性真菌感染的危险因素
Int J Antimicrob Agents. 2008 Nov;32 Suppl 2:S119-23. doi: 10.1016/S0924-8579(08)70012-8.
3
Epidemiology and outcomes of patients with invasive mould infections: a retrospective observational study from a single centre (2005-2009).侵袭性霉菌感染患者的流行病学及转归:一项单中心回顾性观察研究(2005 - 2009年)
Mycoses. 2015 Aug;58(8):470-7. doi: 10.1111/myc.12344. Epub 2015 Jul 7.
4
Changing epidemiology of systemic fungal infections.系统性真菌感染流行病学的变化。
Clin Microbiol Infect. 2008 May;14 Suppl 4:5-24. doi: 10.1111/j.1469-0691.2008.01978.x.
5
Current therapeutic approaches to fungal infections in immunocompromised hematological patients.免疫功能低下血液病患者真菌感染的治疗方法现状。
Blood Rev. 2010 Mar;24(2):51-61. doi: 10.1016/j.blre.2009.11.003. Epub 2010 Jan 6.
6
Emerging moulds: epidemiological trends and antifungal resistance.新兴霉菌:流行病学趋势和抗真菌耐药性。
Mycoses. 2011 Nov;54(6):e666-78. doi: 10.1111/j.1439-0507.2011.02032.x. Epub 2011 Jun 14.
7
Fungal infections in solid organ transplant recipients.实体器官移植受者中的真菌感染
Infect Dis Clin North Am. 1995 Dec;9(4):1045-74.
8
Prophylaxis, pre-emptive or empirical antifungal therapy: which is best in non-lung transplant recipients?预防性、先发制性或经验性抗真菌治疗:在非肺移植受者中哪种最佳?
Int J Antimicrob Agents. 2008 Nov;32 Suppl 2:S149-53. doi: 10.1016/S0924-8579(08)70017-7.
9
[Invasive fungal infection in immunocompromised patients].免疫功能低下患者的侵袭性真菌感染
Rev Iberoam Micol. 2004 Jun;21(2):55-62.
10
Invasive fungal infections in pediatric bone marrow transplant recipients: single center experience of 10 years.儿童骨髓移植受者侵袭性真菌感染:单中心10年经验
Bone Marrow Transplant. 2000 Nov;26(9):999-1004. doi: 10.1038/sj.bmt.1702654.

引用本文的文献

1
Anticandidal Activity of Lipopeptides Containing an LL-37-Derived Peptide Fragment KR12.含有LL-37衍生肽片段KR12的脂肽的抗念珠菌活性
Molecules. 2025 Apr 3;30(7):1598. doi: 10.3390/molecules30071598.
2
Antifungal prophylaxis in high-risk patients with hematologic malignancy: a comparison of practice and guidelines in Türkiye.土耳其血液系统恶性肿瘤高危患者的抗真菌预防:实践与指南的比较
Turk J Med Sci. 2024 Nov 29;55(1):52-64. doi: 10.55730/1300-0144.5942. eCollection 2025.
3
Epidemiology and risk factors of fungal pathogens in sepsis: a prospective nationwide multicenter cohort study.
脓毒症中真菌病原体的流行病学及危险因素:一项全国性前瞻性多中心队列研究
BMC Infect Dis. 2025 Mar 10;25(1):331. doi: 10.1186/s12879-025-10722-y.
4
Evidence-based clinical standard for the diagnosis and treatment of invasive lung aspergillosis in the patient with oncohematologic disease.血液肿瘤患者侵袭性肺曲霉病诊断和治疗的循证临床标准
Braz J Infect Dis. 2025 Mar-Apr;29(2):104517. doi: 10.1016/j.bjid.2025.104517. Epub 2025 Feb 24.
5
Data mining and safety analysis of voriconazole in patients with a hematological malignant tumor based on the FAERS database: differences between children and adults.基于FAERS数据库的血液系统恶性肿瘤患者伏立康唑的数据挖掘与安全性分析:儿童与成人的差异
Front Pharmacol. 2025 Jan 24;16:1524702. doi: 10.3389/fphar.2025.1524702. eCollection 2025.
6
A multivariable prediction model for invasive pulmonary aspergillosis in immunocompromised patients with acute respiratory failure (IPA-GRRR-OH score).免疫功能低下的急性呼吸衰竭患者侵袭性肺曲霉病的多变量预测模型(IPA-GRRR-OH评分)。
Intensive Care Med. 2025 Jan;51(1):72-81. doi: 10.1007/s00134-024-07767-z. Epub 2025 Jan 24.
7
Invasive fungal infection in patients with hematologic malignancies: epidemiology and prognostic factors.血液恶性肿瘤患者的侵袭性真菌感染:流行病学和预后因素。
Pan Afr Med J. 2024 Jul 24;48:130. doi: 10.11604/pamj.2024.48.130.40509. eCollection 2024.
8
Effectiveness of high efficiency particulate (HEPA) air condition combined with the antifungal prophylaxis on incidence, morbidity and mortality of invasive fungal infections in patients with acute myeloid leukemia: a retrospective single-center study.高效微粒(HEPA)空气调节联合抗真菌预防对急性髓系白血病患者侵袭性真菌感染的发生率、发病率和死亡率的影响:一项回顾性单中心研究
Front Oncol. 2024 Oct 17;14:1429221. doi: 10.3389/fonc.2024.1429221. eCollection 2024.
9
The Addition of Systemic Terbinafine to Antifungal Combination Therapy in the Treatment of Disseminated Drug-Resistant Mold Infections in a National Cancer Institute Comprehensive Cancer Center: A Six-Year Study.在国立癌症研究所综合癌症中心,将全身性特比萘芬添加到抗真菌联合治疗中用于治疗播散性耐药霉菌感染的六年研究。
Cureus. 2024 Mar 1;16(3):e55343. doi: 10.7759/cureus.55343. eCollection 2024 Mar.
10
Invasive fungal infections in patients with multiple myeloma: a possible growing problem in hematology and infectious diseases.多发性骨髓瘤患者的侵袭性真菌感染:血液学和传染病领域一个可能日益严重的问题。
Ther Adv Infect Dis. 2024 Mar 26;11:20499361241238518. doi: 10.1177/20499361241238518. eCollection 2024 Jan-Dec.